Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Herpesviridae
|
March 25, 2011
Epstein-Barr virus genetics: talking about the BAC generation
Regina Feederle, Emmalene J Bartlett, Henri-Jacques Delecluse
Immunology
|
July 9, 2002
Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis
Vanessa S Cull, Emmalene J Bartlett, Cassandra M James
Methods in Molecular Medicine
|
July 8, 2005
Interferon subtype gene therapy for regulating cytomegalovirus disease
Cassandra M James, Emmalene J Bartlett, Josephine P Mansfield, et al.
Immunology and Cell Biology
|
September 13, 2002
Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection
Emmalene J Bartlett, Vanessa S Cull, Natalie L Brekalo, et al.
Biological Procedures Online
|
May 8, 2003
Optimization of Naked DNA Delivery for Interferon Subtype Immunotherapy in Cytomegalovirus Infection
Emmalene J. Bartlett, Vanessa S. Cull, Eva N. Mowe, et al.
Blood
|
November 26, 2002
Type I interferon differential therapy for erythroleukemia: specificity of STAT activation
Vanessa S Cull, Peta A Tilbrook, Emmalene J Bartlett, et al.
Immunology and Cell Biology
|
April 6, 2004
Type I IFN-beta gene therapy suppresses cardiac CD8+ T-cell infiltration during autoimmune myocarditis
Emmalene J Bartlett, Jason C Lenzo, Soruba Sivamoorthy, et al.
Virology Journal
|
July 4, 2007
Attenuation and efficacy of human parainfluenza virus type 1 (HPIV1) vaccine candidates containing stabilized mutations in the P/C and L genes
Emmalene J Bartlett, Adam Castaño, Sonja R Surman, et al.
Journal of Virology
|
December 5, 2008
The C proteins of human parainfluenza virus type 1 (HPIV1) control the transcription of a broad array of cellular genes that would otherwise respond to HPIV1 infection
Jim B Boonyaratanakornkit, Emmalene J Bartlett, Emerito Amaro-Carambot, et al.
Blood
|
January 9, 2015
Antigen-armed antibodies targeting B lymphoma cells effectively activate antigen-specific CD4+ T cells
Xiaojun Yu, Marta Ilecka, Emmalene J Bartlett, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Herpesviridae
|
March 25, 2011
Epstein-Barr virus genetics: talking about the BAC generation
Regina Feederle, Emmalene J Bartlett, Henri-Jacques Delecluse
Immunology
|
July 9, 2002
Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis
Vanessa S Cull, Emmalene J Bartlett, Cassandra M James
Methods in Molecular Medicine
|
July 8, 2005
Interferon subtype gene therapy for regulating cytomegalovirus disease
Cassandra M James, Emmalene J Bartlett, Josephine P Mansfield, et al.
Immunology and Cell Biology
|
September 13, 2002
Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection
Emmalene J Bartlett, Vanessa S Cull, Natalie L Brekalo, et al.
Biological Procedures Online
|
May 8, 2003
Optimization of Naked DNA Delivery for Interferon Subtype Immunotherapy in Cytomegalovirus Infection
Emmalene J. Bartlett, Vanessa S. Cull, Eva N. Mowe, et al.
Blood
|
November 26, 2002
Type I interferon differential therapy for erythroleukemia: specificity of STAT activation
Vanessa S Cull, Peta A Tilbrook, Emmalene J Bartlett, et al.
Immunology and Cell Biology
|
April 6, 2004
Type I IFN-beta gene therapy suppresses cardiac CD8+ T-cell infiltration during autoimmune myocarditis
Emmalene J Bartlett, Jason C Lenzo, Soruba Sivamoorthy, et al.
Virology Journal
|
July 4, 2007
Attenuation and efficacy of human parainfluenza virus type 1 (HPIV1) vaccine candidates containing stabilized mutations in the P/C and L genes
Emmalene J Bartlett, Adam Castaño, Sonja R Surman, et al.
Journal of Virology
|
December 5, 2008
The C proteins of human parainfluenza virus type 1 (HPIV1) control the transcription of a broad array of cellular genes that would otherwise respond to HPIV1 infection
Jim B Boonyaratanakornkit, Emmalene J Bartlett, Emerito Amaro-Carambot, et al.
Blood
|
January 9, 2015
Antigen-armed antibodies targeting B lymphoma cells effectively activate antigen-specific CD4+ T cells
Xiaojun Yu, Marta Ilecka, Emmalene J Bartlett, et al.
Page
of 2